A detailed history of Brown Brothers Harriman & CO transactions in Natera, Inc. stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 8 shares of NTRA stock, worth $1,345. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8
Holding current value
$1,345
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$117.67 - $174.0 $941 - $1,392
8 New
8 $1,000
Q3 2022

Nov 10, 2022

BUY
$36.93 - $56.68 $2,326 - $3,570
63 New
63 $3,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Brown Brothers Harriman & CO Portfolio

Follow Brown Brothers Harriman & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

News

Stay updated on Brown Brothers Harriman & CO with notifications on news.